EP2468300
Bóluefnissamsetning með tilbúnu hjálparlyfi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.9.2007EP published:
20.12.2017EP application number:
12153267.5
EP translation filed:
10.1.2018Grant published:
15.2.2018EPO information:
European Patent Register
Max expiry date:
25.9.2027Expiry date:
25.9.2026Next due date:
30.9.2026
Title:
Vaccine composition containing synthetic adjuvant
Timeline
Today
26.9.2007EP application
20.12.2017EP Publication
10.1.2018Translation submitted
15.2.2018Registration published
25.9.2026Expires
Owner
Name:
Infectious Disease Research InstituteAddress:
1616 Eastlake Ave. E Suite 400, 98102, Seattle, WA, US
Inventor
Name:
Reed, Steven G.Address:
Bellevue, WA, US
Name:
Carter, DarrickAddress:
Seattle, WA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
847404 PDate:
26.9.2006Country:
US
Classification
Categories:
A61K 39/39
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 22.8.2018
Expires: 25.9.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 13
Paid: 30.8.2019
Expires: 25.9.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 14
Paid: 8.8.2020
Expires: 25.9.2021
Payer: Örn Þór slf.
Number: 15
Paid: 11.8.2021
Expires: 25.9.2022
Payer: Örn Þór slf.
Number: 16
Paid: 16.8.2022
Expires: 25.9.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 30.6.2023
Expires: 25.9.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 15.8.2024
Expires: 25.9.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 9.9.2025
Expires: 25.9.2026
Payer: Árnason Faktor ehf.